🇺🇸 FDA
Patent

US 9119863

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

granted A61KA61K31/58A61K47/26

Quick answer

US patent 9119863 (Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract) held by The Regents of the University of California expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/58, A61K47/26, A61K47/36, A61K9/0053